Together with a number of companies established at the Pivot Park, Okklo Life Sciences will be at the Biomedica Summit in Aachen, Germany on June 18th and 19th, 2013. We are looking forward to making many new contacts with (potential) partners with whom we will be able to advance our projects and business.
On March 28th, okklo life sciences announces a new collaboration – the BiCycle platform ™. In partnership with two other biotech companies, BioConnection and ChemConnection (also located at the Pivot Park), this platform will deliver specialized services for the synthesis and manufacturing of GMP-quality drug products based on cyclodextrins. In addition, the platform will …
Cyclodextrin-based therapies, Okklo’s field of expertise, seem promising in the treatment of some of these orphan diseases. Therefore, we feel highly committed to contribute to the success of the Gordon Research Conference on Lysosomal Disease (with many other partners, including various patient advocacy groups). We do this by offering some financial support, but also by …
As of early 2012, okklo life sciences has been located at the newly established Life Sciences Park in Oss, The Netherlands. In June, the address was also registered with the Chamber of Commerce , so that okklo now is an integral part of the rapidly growing community of companies that have been joining the Life …
2 Feb 2012 okklo life sciences is entering a collaboration with UMC Radboud (Nijmegen, The Netherlands) for the development of novel therapeutic approaches against multi-drug resistant tuberculosis (MRD-TB). Resistance against treatment with antibiotics is increasingly common in many infectious diseases, and this also is a serious health issue concern …